Iterum Therapeutics launches $20 million at-the-market share offering
PositiveFinancial Markets

Iterum Therapeutics has announced a $20 million at-the-market share offering, a strategic move that could bolster its financial position and support ongoing projects. This offering allows the company to raise capital efficiently, which is crucial for biotech firms as they navigate the complex landscape of drug development. Investors may view this as a positive sign of the company's growth potential and commitment to advancing its pipeline.
— Curated by the World Pulse Now AI Editorial System